升精丸治疗男性不育的临床研究

Clinical Study on Treatment of Male Infertility with Shengjing Pill

采用升精丸对２０２例男性不育少精子症患者进行治疗，结果表明：服药后患者精液的量、液化时间、精子密度、精子活率及活动力均明显改善；部分患者下丘脑－垂体－睾丸性腺轴内分泌功能检测结果，服药后较低水平的卵泡刺激素（ＦＳＨ）、黄体生成素（ＬＨ）和睾酮（Ｔ）已升到正常水平；４５例血清抗精子抗体（ＡｓＡｂ）高滴度患者，服药后其滴度下降到正常水平。服药后检测的各项指标，与服药前比较有显著性差异（Ｐ＜０．００１）。随访１４８例，其配偶妊娠者１１６例，其中足月分娩１０７例，生下婴儿１０８名。

cases of male infertility were treated with Shengjing Pill.After treatment,quantity and quality of sperm were significantly improved(P<0.001),levels of follicle stimulating hormone(FSH),luteinizing hormone(LH) and testosterone(T) were enhanced to normal in 96 patients(P<0.001),levels of anti-sperm-antibody was reduced to normal in 45 cases(P<0.001),of 148 follow ups.Their 116 spouses became pregnant and have borne 108 well-developed babies.